Related references
Note: Only part of the references are listed.Impact of preventive therapy on the risk of breast cancer among women with benign breast disease
Jack Cuzick et al.
BREAST (2015)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
The past, present, and future of cancer incidence in the United States: 1975 through 2020
Hannah K. Weir et al.
CANCER (2015)
A systematic review of factors influencing older adults' decision to accept or decline cancer treatment
Martine T. E. Puts et al.
CANCER TREATMENT REVIEWS (2015)
Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State
Betsy A. Kohler et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial
Jack Cuzick et al.
LANCET ONCOLOGY (2015)
Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State
Betsy A. Kohler et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Factors influencing adherence to cancer treatment in older adults with cancer: a systematic review
M. T. E. Puts et al.
ANNALS OF ONCOLOGY (2014)
Combining the Power of Stories and the Power of Numbers: Mixed Methods Research and Mixed Studies Reviews
Pierre Pluye et al.
ANNUAL REVIEW OF PUBLIC HEALTH, VOL 35 (2014)
Improving decision making about clinical trial participation - a randomised controlled trial of a decision aid for women considering participation in the IBIS-II breast cancer prevention trial
I. Juraskova et al.
BRITISH JOURNAL OF CANCER (2014)
Uptake of tamoxifen in consecutive premenopausal women under surveillance in a high-risk breast cancer clinic
L. S. Donnelly et al.
BRITISH JOURNAL OF CANCER (2014)
Breast Cancer Statistics, 2013
Carol DeSantis et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2014)
Cognitive Factors Associated with Adherence to Oral Antiestrogen Therapy: Results from the Cognition in the Study of Tamoxifen and Raloxifene (Co-STAR) Study
Heidi D. Klepin et al.
CANCER PREVENTION RESEARCH (2014)
Adherence to Endocrine Therapy in Breast Cancer Adjuvant and Prevention Settings
Rowan T. Chlebowski et al.
CANCER PREVENTION RESEARCH (2014)
Effectiveness of a group-based intervention to change medication beliefs and improve medication adherence in patients with rheumatoid arthritis: A randomized controlled trial
Hanneke E. Zwikker et al.
PATIENT EDUCATION AND COUNSELING (2014)
A clinical trial of lovastatin for modification of biomarkers associated with breast cancer risk
Shaveta Vinayak et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Acceptability and Adherence in a Chemoprevention Trial among Women at Increased Risk for Breast Cancer Attending the Modena Familial Breast and Ovarian Cancer Center (Italy)
Elisabetta Razzaboni et al.
BREAST JOURNAL (2013)
A double-blind placebo-controlled study to evaluate endometrial safety and gynaecological symptoms in women treated for up to 5 years with tamoxifen or placebo - A substudy for IBIS I Breast Cancer Prevention Trial
Tiina Palva et al.
EUROPEAN JOURNAL OF CANCER (2013)
Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data
Jack Cuzick et al.
LANCET (2013)
The Right Tool Is What They Need, Not What We Have: A Taxonomy of Appropriate Levels of Precision in Patient Risk Communication
Brian J. Zikmund-Fisher
MEDICAL CARE RESEARCH AND REVIEW (2013)
Preventing breast and ovarian cancers in high-risk BRCA1 and BRCA2 mutation carriers
Ian M. Collins et al.
MEDICAL JOURNAL OF AUSTRALIA (2013)
Understanding Patients' Adherence-Related Beliefs about Medicines Prescribed for Long-Term Conditions: A Meta-Analytic Review of the Necessity-Concerns Framework
Rob Horne et al.
PLOS ONE (2013)
Informed choice about breast cancer prevention: randomized controlled trial of an online decision aid intervention
Ida J. Korfage et al.
BREAST CANCER RESEARCH (2013)
Improving Adherence to Medication in Stroke Survivors: A Pilot Randomised Controlled Trial
Ronan E. O'Carroll et al.
ANNALS OF BEHAVIORAL MEDICINE (2013)
Risk Factors for Breast Cancer for Women Aged 40 to 49 Years A Systematic Review and Meta-analysis
Heidi D. Nelson et al.
ANNALS OF INTERNAL MEDICINE (2012)
Use of tamoxifen and raloxifene for breast cancer chemoprevention in 2010
Erika A. Waters et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Assessing Individual Breast Cancer Risk within the UK National Health Service Breast Screening Program: A New Paradigm for Cancer Prevention
D. Gareth R. Evans et al.
CANCER PREVENTION RESEARCH (2012)
Administration of omega-3 fatty acids and Raloxifene to women at high risk of breast cancer: interim feasibility and biomarkers analysis from a clinical trial
C. Signori et al.
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2012)
Uptake of a randomized breast cancer prevention trial comparing letrozole to placebo in BRCA1/2 mutations carriers: the LIBER trial
Pascal Pujol et al.
FAMILIAL CANCER (2012)
Testing the reliability and efficiency of the pilot Mixed Methods Appraisal Tool (MMAT) for systematic mixed studies review
Romina Pace et al.
INTERNATIONAL JOURNAL OF NURSING STUDIES (2012)
Bone density and structure in healthy postmenopausal women treated with exemestane for the primary prevention of breast cancer: a nested substudy of the MAP.3 randomised controlled trial
Angela M. Cheung et al.
LANCET ONCOLOGY (2012)
Tamoxifen versus Raloxifene versus Exemestane for Chemoprevention
Laura Reimers et al.
CURRENT BREAST CANCER REPORTS (2012)
Women's interest in taking tamoxifen and raloxifene for breast cancer prevention: response to a tailored decision aid
Angela Fagerlin et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Cigarette Smoking, Obesity, Physical Activity, and Alcohol Use As Predictors of Chemoprevention Adherence in the National Surgical Adjuvant Breast and Bowel Project P-1 Breast Cancer Prevention Trial
Stephanie R. Land et al.
CANCER PREVENTION RESEARCH (2011)
Predicting Adherence to Tamoxifen for Breast Cancer Adjuvant Therapy and Prevention
Jennifer H. Lin et al.
CANCER PREVENTION RESEARCH (2011)
Healthcare professional experiences and attitudes on unlicensed/off-label paediatric prescribing and paediatric clinical trials
Tareq Mukattash et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis
Mohammad H. Forouzanfar et al.
LANCET (2011)
Breast cancer risk assessment in a mammography screening program and participation in the IBIS-II chemoprevention trial
Christian R. Loehberg et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Identification of Accrual Barriers Onto Breast Cancer Prevention Clinical Trials A Case-Control Study
Robert H. Houlihan et al.
CANCER (2010)
Prevalence of Tamoxifen Use for Breast Cancer Chemoprevention Among US Women
Erika A. Waters et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing Breast Cancer
Victor G. Vogel et al.
CANCER PREVENTION RESEARCH (2010)
Patient Decisions About Breast Cancer Chemoprevention: A Systematic Review and Meta-Analysis
Mary E. Ropka et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Uptake of breast cancer prevention and screening trials
D. Gareth Evans et al.
JOURNAL OF MEDICAL GENETICS (2010)
Choice of Management of Southern Chinese BRCA Mutation Carriers
Ava Kwong et al.
WORLD JOURNAL OF SURGERY (2010)
Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database
Philippe Autier et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Chemoprevention Indication Score: A user-friendly tool for prevention of breast cancer - Pilot analysis
Rakhshanda Layeequr Rahman et al.
BREAST (2009)
No Effect of Aspirin on Mammographic Density in a Randomized Controlled Clinical Trial
Anne McTiernan et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2009)
Australian clinicians and chemoprevention for women at high familial risk for breast cancer
Louise A. Keogh et al.
HEREDITARY CANCER IN CLINICAL PRACTICE (2009)
International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers
Kelly A. Metcalfe et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Psychological and clinical factors implicated in decision making about a trial of low-dose tamoxifen in hormone replacement therapy users
Gabriella Rondanina et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Improving haemodialysis patients' understanding of phosphate-binding medication: A pilot study of a psycho-educational intervention designed to change patients' perceptions of the problem and treatment
Christina Karamanidou et al.
BRITISH JOURNAL OF HEALTH PSYCHOLOGY (2008)
Atypia in random periareolar fine-needle aspiration affects the decision of women at high risk to take tamoxifen for breast cancer chemoprevention
Vanessa K. Goldenberg et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Pilot trial of a computerized decision aid for breast cancer prevention
Elissa M. Ozanne et al.
BREAST JOURNAL (2007)
Long-term results of tamoxifen prophylaxis for breast cancer-96-month follow-up of the randomized IBIS-I trial
Jack Cuzick et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Effectiveness of telephone counselling by a pharmacist in reducing mortality in patients receiving polypharmacy: randomised controlled trial
Jennifer Y. F. Wu et al.
BMJ-BRITISH MEDICAL JOURNAL (2006)
Risk-reducing surgery, screening and chemoprevention practices of BRCA1 and BRCA2 mutation carriers:: a prospective cohort study
K-A Phillips et al.
CLINICAL GENETICS (2006)
Predicting compliance in a breast cancer prevention trial
Andrew Maurice et al.
BREAST JOURNAL (2006)
Healthy women with a family history of breast cancer: Impact of a tailored genetic counseling intervention on risk perception, knowledge, and menopausal therapy decision making
Ellen T. Matloff et al.
JOURNAL OF WOMENS HEALTH (2006)
Why take it if you don't have anything? Breast cancer risk perceptions and prevention choices at a public hospital
Talya Salant et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2006)
A prospective questionnaire assessment of attitudes and experiences of off label prescribing among hospital based paediatricians
J. S. McLay et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2006)
Patient-reported symptoms and quality of life during treatment with tamoxifen or raloxifene for breast cancer prevention - The NSABP study of tamoxifen and raloxifene (STAR) P-2 trial
Stephanie R. Land et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes - The NSABP study of tamoxifen and raloxifene (STAR) P-2 trial
Victor G. Vogel et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Tamoxifen for breast cancer chemoprevention: Low uptake by high-risk women after evaluation of a breast lump
R Taylor et al.
ANNALS OF FAMILY MEDICINE (2005)
The use of preventive measures among healthy women who carry a BRCA1 or BRCA2 mutation
KA Metcalfe et al.
FAMILIAL CANCER (2005)
Women's decision making about whether or not to use breast cancer chemoprevention
A Altschuler et al.
WOMEN & HEALTH (2005)
Decision-making about tamoxifen in women at high risk for breast cancer: Clinical and psychological factors
SL Bober et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Acceptance of tamoxifen chemoprevention by physicians and women at risk
J Tchou et al.
CANCER (2004)
Shared decision making about screening and chemoprevention - A suggested approach from the US Preventive Services Task Force
SL Sheridan et al.
AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2004)
Estimates of the number of US women who could benefit from tamoxifen for breast cancer chemoprevention
AN Freedman et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Tamoxifen and depression: More evidence from the National Surgical Adjuvant Breast and Bowel Project's Breast Cancer Prevention (P-1) randomized study
R Day et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Chemoprevention of breast cancer with selective estrogen receptor modulators: Views from broadly diverse focus groups of women with elevated risk for breast cancer
MS Cyrus-David et al.
PSYCHO-ONCOLOGY (2001)
Uptake of screening and prevention in women at very high risk of breast cancer
DGR Evans et al.
LANCET (2001)
Tamoxifen for the prevention of breast cancer: Psychosocial impact on women participating in two randomized controlled trials
L Fallowfield et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Share Paper
